JPH0265778A - Isolation of cell culture product and change of culture medium - Google Patents
Isolation of cell culture product and change of culture mediumInfo
- Publication number
- JPH0265778A JPH0265778A JP63214481A JP21448188A JPH0265778A JP H0265778 A JPH0265778 A JP H0265778A JP 63214481 A JP63214481 A JP 63214481A JP 21448188 A JP21448188 A JP 21448188A JP H0265778 A JPH0265778 A JP H0265778A
- Authority
- JP
- Japan
- Prior art keywords
- cells
- product
- medium
- culture medium
- hollow fiber
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000004113 cell culture Methods 0.000 title claims abstract description 8
- 239000001963 growth medium Substances 0.000 title abstract description 28
- 238000002955 isolation Methods 0.000 title 1
- 239000012510 hollow fiber Substances 0.000 claims abstract description 69
- 238000000034 method Methods 0.000 claims description 15
- -1 polyethylene Polymers 0.000 claims description 10
- 239000011148 porous material Substances 0.000 claims description 9
- 229920002284 Cellulose triacetate Polymers 0.000 claims description 5
- NNLVGZFZQQXQNW-ADJNRHBOSA-N [(2r,3r,4s,5r,6s)-4,5-diacetyloxy-3-[(2s,3r,4s,5r,6r)-3,4,5-triacetyloxy-6-(acetyloxymethyl)oxan-2-yl]oxy-6-[(2r,3r,4s,5r,6s)-4,5,6-triacetyloxy-2-(acetyloxymethyl)oxan-3-yl]oxyoxan-2-yl]methyl acetate Chemical compound O([C@@H]1O[C@@H]([C@H]([C@H](OC(C)=O)[C@H]1OC(C)=O)O[C@H]1[C@@H]([C@@H](OC(C)=O)[C@H](OC(C)=O)[C@@H](COC(C)=O)O1)OC(C)=O)COC(=O)C)[C@@H]1[C@@H](COC(C)=O)O[C@@H](OC(C)=O)[C@H](OC(C)=O)[C@H]1OC(C)=O NNLVGZFZQQXQNW-ADJNRHBOSA-N 0.000 claims description 5
- 229920002492 poly(sulfone) Polymers 0.000 claims description 4
- 229920001747 Cellulose diacetate Polymers 0.000 claims description 3
- 239000004952 Polyamide Substances 0.000 claims description 3
- 239000004698 Polyethylene Substances 0.000 claims description 3
- 239000004743 Polypropylene Substances 0.000 claims description 3
- 229920002647 polyamide Polymers 0.000 claims description 3
- 229920000728 polyester Polymers 0.000 claims description 3
- 229920000573 polyethylene Polymers 0.000 claims description 3
- 229920001155 polypropylene Polymers 0.000 claims description 3
- 229920001343 polytetrafluoroethylene Polymers 0.000 claims description 3
- 239000004810 polytetrafluoroethylene Substances 0.000 claims description 3
- 239000004627 regenerated cellulose Substances 0.000 claims description 3
- 239000002609 medium Substances 0.000 description 33
- 239000000047 product Substances 0.000 description 33
- 210000004027 cell Anatomy 0.000 description 32
- 239000012466 permeate Substances 0.000 description 12
- 210000002966 serum Anatomy 0.000 description 9
- 239000000126 substance Substances 0.000 description 8
- 230000003213 activating effect Effects 0.000 description 7
- 239000007788 liquid Substances 0.000 description 7
- 238000003756 stirring Methods 0.000 description 5
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 4
- 102000008072 Lymphokines Human genes 0.000 description 4
- 108010074338 Lymphokines Proteins 0.000 description 4
- 238000012258 culturing Methods 0.000 description 4
- 238000010586 diagram Methods 0.000 description 4
- 108060003951 Immunoglobulin Proteins 0.000 description 3
- 210000004748 cultured cell Anatomy 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 102000018358 immunoglobulin Human genes 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 238000013022 venting Methods 0.000 description 3
- 108010088751 Albumins Proteins 0.000 description 2
- 102000009027 Albumins Human genes 0.000 description 2
- 102000008946 Fibrinogen Human genes 0.000 description 2
- 108010049003 Fibrinogen Proteins 0.000 description 2
- 102000014150 Interferons Human genes 0.000 description 2
- 108010050904 Interferons Proteins 0.000 description 2
- 239000013543 active substance Substances 0.000 description 2
- 229910002092 carbon dioxide Inorganic materials 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 230000002349 favourable effect Effects 0.000 description 2
- 229940012952 fibrinogen Drugs 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 210000004698 lymphocyte Anatomy 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 238000012544 monitoring process Methods 0.000 description 2
- 238000004382 potting Methods 0.000 description 2
- 239000011800 void material Substances 0.000 description 2
- 101100243025 Arabidopsis thaliana PCO2 gene Proteins 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- 102000018997 Growth Hormone Human genes 0.000 description 1
- 108010051696 Growth Hormone Proteins 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 102000003990 Urokinase-type plasminogen activator Human genes 0.000 description 1
- 108090000435 Urokinase-type plasminogen activator Proteins 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- 210000002798 bone marrow cell Anatomy 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 239000006285 cell suspension Substances 0.000 description 1
- 238000007872 degassing Methods 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000012091 fetal bovine serum Substances 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 239000000122 growth hormone Substances 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 229940079322 interferon Drugs 0.000 description 1
- 229940047124 interferons Drugs 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 239000012679 serum free medium Substances 0.000 description 1
- 229920002803 thermoplastic polyurethane Polymers 0.000 description 1
- 229960005356 urokinase Drugs 0.000 description 1
Landscapes
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
Abstract
Description
【発明の詳細な説明】
〔産業上の利用分野〕
本発明は細胞を培養してえられる産生物の取出しおよび
培地の交換方法に関する。DETAILED DESCRIPTION OF THE INVENTION [Industrial Field of Application] The present invention relates to a method for removing products obtained by culturing cells and replacing a medium.
〔従来の技術・発明が解決しようとする課題〕近年、バ
イオテクノロジーの進歩にともない微生物や細胞などを
培養して利用する装置も種々提案されてきている。[Problems to be solved by conventional techniques and inventions] In recent years, with the progress of biotechnology, various devices for culturing and utilizing microorganisms, cells, etc. have been proposed.
たとえば細胞を培養する装置として、回分操作の必要な
反応器を一部連続化した半回分反応器、さらには四分操
作を連続操作に改善した連続槽重反応器などの槽型反応
器や、連続操作に適した前型反応器などが提案され、利
用されてきている。For example, as a device for culturing cells, there are tank-type reactors such as semi-batch reactors, which are partially continuous reactors that require batch operation, and continuous tank heavy reactors, which are improved from quarter-part operation to continuous operation. Front-type reactors suitable for continuous operation have been proposed and used.
前記改善は、回分操作を半連続化、連続化するという点
ではそれなりの効果があるが、いずれも細胞と培地およ
びその他必要とされる成分(たとえば血清、リンホカイ
ンなどの生理活性物質など)とを1つの系とし、これを
撹拌などすることにより所望の培養された細胞やを用産
生物をうる方法であり、培地を交換して好ましい状態で
培養するというような方法ではない。The above improvements have some effect in making batch operations semi-continuous or continuous, but in both cases, it is difficult to separate cells, culture medium, and other necessary components (e.g., serum, physiologically active substances such as lymphokines, etc.). This is a method in which a desired cultured cell or product is obtained by stirring the system in one system, and is not a method in which the culture medium is replaced and cultured under a preferable condition.
そして培養された細胞や有用産生物は多量の培地などと
ともに存在するため、目的物の分離・精製が容易でなく
、培養された細胞や産生物の濃度をいかにして高めるか
、また細胞や産生物の取出操作の妨げとなる培地などを
いかにして少なくするか、などが重要な課題となってい
る。Since cultured cells and useful products exist together with a large amount of medium, it is not easy to separate and purify the desired product, and it is difficult to increase the concentration of cultured cells and products. An important issue is how to reduce the amount of culture medium that interferes with the extraction operation of living organisms.
本発明は前記のごとき従来法における欠点を改善するた
めになされたものであり、細胞を培養し、その産生物を
うるに際し、該産生物の取出しを細胞は透過しないが産
生物は透過する中空糸束を含んでなる装置(■)(以下
、(I)の中空糸束装置ともいう)を用いて行ない、培
地の取出1、を細胞および産生物は透過しないが培地は
透過する中空糸束を含んでなる装置(N)(以下、(H
)の中空糸束装置ともいう)を用いて行なうことを特徴
とする細胞培養産生物の取出しおよび培地の交換方法に
関する。The present invention has been made in order to improve the drawbacks of the conventional methods as described above. Removal of the culture medium (1) is carried out using a device (■) comprising a fiber bundle (hereinafter also referred to as the hollow fiber bundle device of (I)), using a hollow fiber bundle that does not pass through the cells and products but allows the culture medium to pass through. (N) (hereinafter referred to as (H)
This invention relates to a method for removing cell culture products and replacing a medium, which is carried out using a hollow fiber bundle device (also referred to as a hollow fiber bundle device).
本発明においては、細胞および有用代謝物たる産生物は
透過しないが、培地は透過する帽)の中空糸束装置によ
り培地が取出されて培養系が好ましい状態に維持され、
産生物濃度が高められ、産生物は透過するが細胞は透過
しない(I)の中空糸束装置により産生物の濃度が高め
られた培養系から産生物が取出される。そしてこの操作
は無菌状態で連続的に行なわれる。In the present invention, the culture medium is removed by a hollow fiber bundle device (cap) that does not permeate cells and products such as useful metabolites, but allows the medium to pass through, and the culture system is maintained in a favorable state.
The product is removed from the culture system in which the product concentration is increased by means of a hollow fiber bundle device (I) which permeates the product but not the cells. This operation is performed continuously under aseptic conditions.
さらに、(I)、(II)の中空糸束装置は装置の大き
さに比して透過にa効な表面積が大きく、小さな装置で
効率よく取出しが行なわれる。Furthermore, the hollow fiber bundle devices (I) and (II) have a large surface area effective for permeation compared to the size of the device, and can be efficiently taken out with a small device.
本発明においては、細胞の培養によりえられた産生物を
取出すに際し、(II)の中空糸束装置により培地が取
出されて培養系が好ましい状態に維持され、(I)の中
空糸束装置により産生物が取出される。In the present invention, when taking out products obtained by culturing cells, the medium is taken out by the hollow fiber bundle device (II) and the culture system is maintained in a favorable state, and the hollow fiber bundle device (I) The product is removed.
fI)の中空糸束装置をその一例である第1図に示す装
置に基づいて説明する。fI)'s hollow fiber bundle device will be explained based on the device shown in FIG. 1, which is an example thereof.
(I1の中空糸束装置(I)は、細胞は透過しないが、
培養により産生される有用な産生物は透過し、培養系外
に産生物を取出すための装置であり、中空糸束(2の両
端が支持手段(3)、(3゛)で支持され、上端および
下端が開口されており、該開口部(4)、(4゛)には
液体通路(5)、(5゛)を有するキャップ(6)、(
6°)が被冠されている装置である。(The hollow fiber bundle device (I) of I1 does not penetrate cells, but
This is a device for permeating useful products produced by culture and taking out the products outside the culture system.Both ends of the hollow fiber bundle (2) are supported by support means (3), (3゛), and a cap (6) whose lower end is open and which has liquid passages (5), (5') in the openings (4), (4');
6°) is the device that is crowned.
第1図の装置における中空糸束は上端が開放された例で
あり、使用前の中空糸束装置のブライミングが容易であ
り、また上下対称形に形成可能なので製造も容易である
が、必ずしも上端は開放されている必要はなく、支持手
段(3)やキャップ(4)によって封鎖された形になっ
ていてもよい。ただし、上端が支持手段(3)などによ
って直接封鎖されたものは使用前の中空糸束装置のブラ
イミングが困難であり、またブライミングをしないばあ
いにはエアブロツクがおこり、液の回収効率がわるくな
る。The hollow fiber bundle in the apparatus shown in Fig. 1 is an example in which the upper end is open, and the hollow fiber bundle apparatus can be easily brimmed before use, and can be formed vertically symmetrically, making it easy to manufacture. does not need to be open, but may be closed by a support means (3) or a cap (4). However, if the upper end is directly blocked by the support means (3) etc., it is difficult to brim the hollow fiber bundle device before use, and if brimming is not done, air block will occur and the liquid recovery efficiency will be reduced. .
中空糸束(′2Jを構成する中空糸としては、細胞は透
過しないが産生物は透過するものであるかぎりとくに限
定はないが、通常平均ポアサイズ50Å〜l−程度、さ
らには50A〜0.2Brn程度(たとえば産生物の分
子量がイムノグロブリンM(IgM)やフィブリノーゲ
ンのように10万〜 100万のばあいには、平均ポア
サイズ500〜5000人程度、アルブミンのように1
万〜10万のばあいには、平均ポアサイズ50〜500
人程度)の中空糸が好ましく使用される。The hollow fibers constituting the hollow fiber bundle ('2J) are not particularly limited as long as they do not permeate cells but permeate products; (For example, if the molecular weight of the product is 100,000 to 1 million, such as immunoglobulin M (IgM) or fibrinogen, the average pore size is about 500 to 5,000, and if the molecular weight is 1,000,000 to 1,000,000 like albumin.
In the case of 10,000 to 100,000, the average pore size is 50 to 500.
Hollow fibers (about the size of a human body) are preferably used.
該中空糸を構成する材質などにもとくに限定はないが、
培地中に存在する産生物を透過させるため、たとえば再
生セルロースなどの親水性材1)が好ましい。たとえば
セルローストリアセテート、セルロースジアセテート、
ポリエチレン、ポリプロピレン、ポリエステル、ポリア
ミド、ポリテトラフルオロエチレン、ポリスルホンなど
の親水性でない材料からなる中空糸のばあいには、表面
を親水化した中空糸を用いる必要がある。There are no particular limitations on the material constituting the hollow fibers, but
Hydrophilic materials 1), such as for example regenerated cellulose, are preferred in order to allow the products present in the medium to permeate. For example, cellulose triacetate, cellulose diacetate,
In the case of hollow fibers made of non-hydrophilic materials such as polyethylene, polypropylene, polyester, polyamide, polytetrafluoroethylene, and polysulfone, it is necessary to use hollow fibers whose surfaces are made hydrophilic.
前記中空糸は通常300〜600本程度束ねて両端を、
たとえばウレタン樹脂などでボッティングして支持手段
(3)、(3°)となるポツティング部を形成すること
により中空糸束(2)とされる。Usually about 300 to 600 hollow fibers are bundled and both ends are tied together.
For example, the hollow fiber bundle (2) is formed by potting with urethane resin or the like to form potting portions that serve as support means (3) and (3°).
中空糸を束ねた際の断面形状、長さなどは、適宜選択す
ればよいが、培地との接触面積が大きくなるようにする
のが好ましく、通常円形の断面形状のものが採用される
。The cross-sectional shape, length, etc. of the bundled hollow fibers may be selected as appropriate, but it is preferable to make the contact area with the culture medium large, and those having a circular cross-sectional shape are usually adopted.
(II)の中空糸束装置は細胞および産生物は透過しな
いが、培地を透過して排液し、培地を好ましい状態に維
持するためのものである。The hollow fiber bundle device (II) is impermeable to cells and products, but permeates and drains the medium to maintain the medium in a desirable state.
(if)の中空糸束装置の構造などは(I)の中空糸束
装置と同じでよく、これら2つの装置の差異は透過させ
るべき物質が異なる、すなわちmの中空糸束装置のばあ
いは産生物およびこれより小さい物質(培地を含む)で
あるのに対し、(II)の中空糸束装置のばあいは産生
物は透過せず、主として培地を透過する点にある。した
がって、これら装置を構成する中空糸の平均ポアサイズ
が異なり、(Illの中空糸束装置中の中空糸の平均ポ
アサイズは30〜50人である。平均ポアサイズ30〜
50人の中空糸を用いたばあいには、血清やリンホカイ
ンなどの細胞活性化物質は透過せずに培地は透過するた
め、血清や細胞活性化物質を節約できる。The structure of the hollow fiber bundle device (if) may be the same as the hollow fiber bundle device (I), and the difference between these two devices is that the substances to be transmitted are different, that is, in the case of the hollow fiber bundle device of m. In contrast, in the case of the hollow fiber bundle device (II), the product does not permeate, but mainly permeates the medium. Therefore, the average pore size of the hollow fibers constituting these devices is different (the average pore size of the hollow fibers in the hollow fiber bundle device of Ill.
When 50 hollow fibers are used, serum and cell activating substances such as lymphokines do not pass through, but the medium passes through, so serum and cell activating substances can be saved.
つぎに本発明の方法を、本発明の方法に用いる培養装置
の一例である第2図に示す装置に基づき説明する。Next, the method of the present invention will be explained based on the apparatus shown in FIG. 2, which is an example of a culture apparatus used in the method of the present invention.
第2図において(7)は細胞培養装置、(8)は培地に
細胞、血清、リンホカインなどを含有せしめた培養液の
容器である培地容器、(I)は細胞は透過しないが産生
物は透過する中空糸束を含んでなる中空糸束装置、(9
)は細胞および産生物は透過しないが培地は透過する中
空糸束を含んでなる中空糸束装置、ω)は培地などを供
給する培地供給手段、01)はエアフィルター側を有す
るガス抜き手段、D、04)は中空糸束装置(I)およ
び(9)とそれぞれ連通ずる液体通路を有する保持手段
であり、その上端がコックなどで開放可能に閉鎖されて
いる。In Figure 2, (7) is a cell culture device, (8) is a culture medium container that is a container for culture solution containing cells, serum, lymphokines, etc., and (I) is a cell culture device that does not permeate cells, but does permeate products. A hollow fiber bundle device comprising a hollow fiber bundle (9)
) is a hollow fiber bundle device comprising a hollow fiber bundle that does not permeate cells and products but allows permeation of a medium; ω) is a medium supply means for supplying a medium, etc.; 01) is a degassing means having an air filter side; D, 04) is a holding means having liquid passages communicating with the hollow fiber bundle devices (I) and (9), respectively, and its upper end is closed so as to be openable by a cock or the like.
培地などの供給は培地供給手段Mにより行なわれる。こ
の際、培地容器(8)内の空気を抜くためガス抜き手段
011の開放下で行なうのが好ましい。The medium and the like are supplied by medium supply means M. At this time, it is preferable to perform this with the gas venting means 011 open in order to vent the air in the culture medium container (8).
培養する細胞の供給などは、培地供給手段哨により行な
ってもよいが、別に設けるのが、培地を連続的に供給し
ながら産生物や培地を連続的に取出す連続操作に適して
いるなどの点から好ましい。The cells to be cultured may be supplied by a medium supply means, but a separate medium supply means is suitable for continuous operation in which the culture medium is continuously supplied and the products and the medium are continuously taken out. preferred.
培地容器(8)に培養すべき細胞、血清、リンホカイン
などの細胞活性化物質、培地などが供給され、細胞の培
養条件に応じた温度などの条件下、培養が行なわれる。Cells to be cultured, serum, a cell activating substance such as lymphokine, a medium, and the like are supplied to a culture medium container (8), and culture is performed under conditions such as temperature depending on the culture conditions of the cells.
この際、エアポンプなどにより、たとえば0.2虜程度
のエアフィルターをとおしてガス供給手段(図示されて
いない)からガスが供給され、ガス交換が行なわれ、排
気ガスが、たとえばガス抜き手段(Illから排気され
る。また、培地供給手段ωから培地などが供給される。At this time, gas is supplied from a gas supply means (not shown) using an air pump or the like through an air filter of about 0.2 mm, gas exchange is performed, and the exhaust gas is In addition, the medium and the like are supplied from the medium supply means ω.
培養により産生された有用産生物面は、たとえば第3図
に示すように、+1)の中空糸束装置を構成する中空糸
Oeのポア0力を通って培地中の栄養物(ト)や、たと
えば細胞活性化物質09が産生物もよりも中空糸田を透
過しやすいばあいには、細胞活性化物質鉋などとともに
(I)の中空糸束装置から取出される。For example, as shown in FIG. 3, the useful products produced by the culture pass through the pores of the hollow fibers Oe constituting the hollow fiber bundle device (+1), and the nutrients (g) in the medium, For example, if the cell activating substance 09 is more likely to permeate the hollow fiber than the product, it is taken out from the hollow fiber bundle device (I) together with the cell activating substance plane.
なお第3図における囚は細胞、伽は血清である。In Fig. 3, the cells are cells, and the cells are serum.
この際、第4図に示すように、[11)の中空糸束装置
を構成する中空糸nにより、血清(2Ilや細胞活性化
物質Ogを含まない培地が(II)の中空県東装置から
取出される。At this time, as shown in FIG. 4, the medium containing serum (2Il and cell activating substance Og) is transferred from the hollow Kento device (II) by the hollow fibers n constituting the hollow fiber bundle device (11). taken out.
mの中空県東装置による産生物の取出し、(ff)の中
空県東装置による培地の排出の際に、サイホン効果によ
る陰圧のみでは不充分なばあいには、それぞれの取出し
ラインの、台にポンプなどの手段を設けてもよいことは
当然のことである。When taking out the product using the hollow Kento device (m) and discharging the culture medium by the hollow Kento device (ff), if the negative pressure due to the siphon effect is insufficient, It goes without saying that means such as a pump may be provided.
本発明の方法に用いる装置には撹拌手段は必ずしも必要
ではないが、撹拌手段を設けて培地を撹拌すると、培地
を一定の状態に維持しやすくなり、細胞を培養しやすく
なる。なおこの際、(I)の中空県東装置、fit)の
中空県東装置として、たとえば空隙のある枠体を存する
ような装置を用いるのが好ましい。Although a stirring means is not necessarily required for the apparatus used in the method of the present invention, if a stirring means is provided to stir the medium, it becomes easier to maintain the medium in a constant state, and it becomes easier to culture the cells. In this case, it is preferable to use a device having a frame with a gap, for example, as the hollow Kento device (I) and the hollow Kento device (fit).
前記枠体は、撹拌によりゆれうごきトラブルが生じやす
い中空糸束(21を固定するためのものであるから、な
るべく培地中の産生物などの通過がおこりやすいもので
あるのが好ましく、このような目的を達成しうるしので
あるかぎり、形状、大きさなどにはとくに限定はない。Since the frame is for fixing the hollow fiber bundle (21) which is likely to cause problems due to shaking due to stirring, it is preferable that the frame is one that allows products in the culture medium to easily pass through. There are no particular limitations on shape, size, etc. as long as the purpose can be achieved.
それゆえ、枠体に存在する空隙の形状も、たとえば巾広
く、長いストリップ状の空隙であってもよく、スリット
状、格子状、円形〜楕円形などの空隙であってもよい。Therefore, the shape of the void existing in the frame may be, for example, a wide, long strip-like void, a slit-like shape, a lattice-like shape, a circular to an elliptical shape, or the like.
また空隙率としては中空糸束(2を固定しうる限りなる
べく大きい方が好ましい。Further, the porosity is preferably as large as possible as long as the hollow fiber bundle (2) can be fixed.
第2図には培養中の培地の状態をモニターする手段など
は記載されていないが、随時モニターしながら培養しう
ることは当然のことである。Although FIG. 2 does not show any means for monitoring the condition of the medium during culture, it is a matter of course that culture can be carried out while monitoring the condition from time to time.
本発明の方法により培養される細胞としては、たとえば
リンパ球、骨髄細胞、マクロファージなどが、その際に
使用される細胞活性化物質としては、たとえばリンホカ
インやインターフェロンなどが、さらに培地としては、
たとえば牛胎児血清培地、無血清培地、ヒト血清培地な
どがあげられる。そして産生物としては、たとえばイム
ノグロブリン間1フィブリノーゲン、アルブミン、リン
ホカイン、インシュリン、インターフェロン、ウロキナ
ーゼ、成長ホルモン、モノクローナル抗体などの生理活
性物質などがあげられる。Cells to be cultured by the method of the present invention include, for example, lymphocytes, bone marrow cells, macrophages, etc. Cell activators used at this time include, for example, lymphokines and interferons, and the culture medium includes:
Examples include fetal bovine serum medium, serum-free medium, and human serum medium. Examples of the products include physiologically active substances such as immunoglobulin fibrinogen, albumin, lymphokine, insulin, interferon, urokinase, growth hormone, and monoclonal antibodies.
つぎに本発明の方法を実施例に基づいて説明する。Next, the method of the present invention will be explained based on examples.
実施例1 第2図に示す装置とほぼ同様の装置を用いた。Example 1 An apparatus substantially similar to that shown in FIG. 2 was used.
第2図における培地容器(8)は硬質ガラス製で容ff
i3300ml、直径約150smX高さ約190+n
の円筒状容器、(I)の中空県東装置は、親水化された
セルローストリアセテート製の平均ポアサイズ0.1遍
の中空糸300本を束ねて有効長が120 amになる
ようにボッティングしたもの(全表面積250cj)で
、中空糸の両端は開口しており、それぞれ液体通路を有
するキャップが被冠されている。(Illの中空県東装
置は、親水化されたセルローストリアセテート製の平均
ポアサイズ30人の中空糸300本を束ねて有効長が1
20 mmになるようにボッティングしたもの(全表面
積250cj)で、中空糸の両端は開口しており、液体
通路を存するキャップが被冠されている。そして培地容
器(8)を外部から遮断する蓋体に、前記m、(「)の
中空県東装置(I)、(9)、培地供給手段障および0
.2Jaのエアフィルター(I21を有するガス抜き手
段01)が配置された装置である。なお、前記(I)、
(II)の中空県東装置(I)、(9)はそれぞれの保
持手段0.0Φにより保持されており、上端は閉鎖され
ていた。また、エアフィルター(0,2加)を介してエ
アポンプが取付けられており(図示していない)、ガス
供給が行なわれた。The culture medium container (8) in Fig. 2 is made of hard glass and has a capacity of
i3300ml, diameter approx. 150sm x height approx. 190+n
The cylindrical container and (I) hollow Kento device are made by bundling 300 hollow fibers made of hydrophilized cellulose triacetate with an average pore size of 0.1 and botting them so that the effective length is 120 am. (Total surface area: 250 cj), both ends of the hollow fiber are open, and each end is covered with a cap having a liquid passage. (Ill's Hollow Kento Equipment is made by bundling 300 hollow fibers made of hydrophilic cellulose triacetate with an average pore size of 30, and has an effective length of 1.
Both ends of the hollow fibers are open and covered with caps containing liquid passages. Then, on the lid body that shuts off the culture medium container (8) from the outside, the hollow Kento device (I) (I), (9), the medium supply means and the
.. This device is equipped with a 2Ja air filter (gas venting means 01 having I21). Note that (I) above,
(II) The hollow Kento devices (I) and (9) were held by respective holding means of 0.0Φ, and the upper ends were closed. Further, an air pump (not shown) was attached via an air filter (0,2 addition) to supply gas.
ガス抜き手段01)の開放下、培地としてRPMI−1
640(味の素■製) 10100Qが供給されたのち
、リンパ球106個/ ml X 100m1、血清
10m1、リンホカイン200単位からなる細胞浮遊成
約110 mlを培地容器(8)に供給した。そののち
、37℃で培養を行なった。この間、培地供給手段刀が
ら培地を1ml/1nの割合で供給するとともに、エア
ポンプを用いてCO2を5容量%含存する空気を流量1
0m1/minで供給して20日間培養した。With the gas venting means 01) open, RPMI-1 was added as a medium.
640 (manufactured by Ajinomoto ■) 10100Q was supplied, and then 110 ml of cell suspension consisting of 106 lymphocytes/ml x 100 ml, 10 ml of serum, and 200 units of lymphokine was supplied to the medium container (8). Thereafter, culture was performed at 37°C. During this time, the culture medium is supplied from the medium supply means at a rate of 1ml/1n, and air containing 5% by volume of CO2 is supplied using an air pump at a flow rate of 1ml/1n.
The cells were supplied at a rate of 0 ml/min and cultured for 20 days.
培養中、1日ごとに培地のpi、炭酸ガス分圧(PCO
z )を測定し、7.2≦pl+≦7.3.36mm1
1g≦PCO2≦40mLI1gであることを確かめた
。During culture, the pi and partial pressure of carbon dioxide (PCO) of the medium are adjusted every day.
z), 7.2≦pl+≦7.3.36mm1
It was confirmed that 1g≦PCO2≦40mLI1g.
また(I)の中空糸束装置から産生物であるイムノグロ
ブリンN1を含有する液を0.1ml/minの割合で
回収し、(n)の中空糸束装置から培地を0.9 ml
/ akinの割合で排液した。In addition, a liquid containing the product immunoglobulin N1 was collected from the hollow fiber bundle device (I) at a rate of 0.1 ml/min, and 0.9 ml of the culture medium was collected from the hollow fiber bundle device (n).
The fluid was drained at a rate of /akin.
本発明の方法によると、無菌的、連続的に産生物が産生
され、該産生物を含有する液をコンパクトな装置を用い
て取出すことができる。また、培地に付加される細胞活
性化物質を節約できる。According to the method of the present invention, a product is produced aseptically and continuously, and a liquid containing the product can be removed using a compact device. Furthermore, cell activating substances added to the culture medium can be saved.
(図面の主要符号)
(I) =(I)(I)の中空糸束装置(2) 、中空
糸束
(9):劃)の中空糸束装置
に:産生物
頭:細 胞(Main symbols in the drawing) (I) = (I) Hollow fiber bundle device (2) of (I), Hollow fiber bundle (9): Hollow fiber bundle device of 劃): Product head: Cell
第1図は本発明の方法に用いる装置に使用されるHの中
空糸束装置の一例に関する説明図、第2図は本発明の方
法に用いる装置の一例に関する説明図、第3図は+11
の中空糸束装置で産生物が取出される状態を示す説明図
、第4図はflllの中空糸束装置で培地が取出される
状態を示す説明図である。
′A11 図
第2口FIG. 1 is an explanatory diagram of an example of the H hollow fiber bundle device used in the method of the present invention, FIG. 2 is an explanatory diagram of an example of the device used in the method of the present invention, and FIG. 3 is a +11
FIG. 4 is an explanatory diagram showing a state in which a product is taken out by a hollow fiber bundle device. FIG. 'A11 Diagram 2nd port
Claims (1)
の取出しを細胞は透過しないが産生物は透過する中空糸
束を含んでなる装置( I )を用いて行ない、培地の取
出しを細胞および産生物は透過しないが培地は透過する
中空糸束を含んでなる装置(II)を用いて行なうことを
特徴とする細胞培養産生物の取出しおよび培地の交換方
法。 2 前記装置( I )における中空糸束が、平均ポアサ
イズ50Å〜0.5μmを有する再生セルロース製の中
空糸、または親水化されたセルローストリアセテート、
セルロースジアセテート、ポリエチレン、ポリプロピレ
ン、ポリエステル、ポリアミド、ポリテトラフルオロエ
チレンもしくはポリスルホン製の中空糸からなる請求項
1記載の方法。 3 前記装置(II)における中空糸束が、平均ポアサイ
ズ30〜50Åを有する再生セルロース製の中空糸、ま
たは親水化されたセルローストリアセテート、セルロー
スジアセテート、ポリエチレン、ポリプロピレン、ポリ
エステル、ポリアミド、ポリテトラフルオロエチレンも
しくはポリスルホン製の中空糸からなる請求項1記載の
方法。[Claims] 1. When cells are cultured and their products are obtained, the products are taken out using a device (I) comprising a hollow fiber bundle that does not pass through the cells but allows the products to pass through. A method for removing a cell culture product and exchanging a medium, characterized in that the medium is removed using a device (II) comprising a hollow fiber bundle that does not pass through cells and products but allows the medium to pass through. 2. The hollow fiber bundle in the device (I) is a hollow fiber made of regenerated cellulose having an average pore size of 50 Å to 0.5 μm, or hydrophilized cellulose triacetate,
2. The method of claim 1, comprising hollow fibers made of cellulose diacetate, polyethylene, polypropylene, polyester, polyamide, polytetrafluoroethylene or polysulfone. 3 The hollow fiber bundle in the device (II) is made of regenerated cellulose hollow fibers having an average pore size of 30 to 50 Å, or hydrophilized cellulose triacetate, cellulose diacetate, polyethylene, polypropylene, polyester, polyamide, polytetrafluoroethylene. The method according to claim 1, comprising hollow fibers made of polysulfone or polysulfone.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP63214481A JP2507552B2 (en) | 1988-08-29 | 1988-08-29 | Method for removing cell culture product and changing medium |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP63214481A JP2507552B2 (en) | 1988-08-29 | 1988-08-29 | Method for removing cell culture product and changing medium |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH0265778A true JPH0265778A (en) | 1990-03-06 |
JP2507552B2 JP2507552B2 (en) | 1996-06-12 |
Family
ID=16656428
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP63214481A Expired - Fee Related JP2507552B2 (en) | 1988-08-29 | 1988-08-29 | Method for removing cell culture product and changing medium |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP2507552B2 (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2017519497A (en) * | 2014-06-04 | 2017-07-20 | アムジエン・インコーポレーテツド | Method for recovering mammalian cell culture |
CN111406105A (en) * | 2018-11-02 | 2020-07-10 | 上海药明生物技术有限公司 | Enhanced perfusion cell culture method with continuous harvest and no cell discharge |
CN115003787A (en) * | 2020-01-15 | 2022-09-02 | 上海药明生物技术有限公司 | Apparatus and method for continuous harvesting of biological material produced by cultured cells |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS60102187A (en) * | 1983-11-07 | 1985-06-06 | Nippon Zenyaku Kogyo Kk | Continuous cultivation of large amount of cell product |
JPS60156378A (en) * | 1984-01-26 | 1985-08-16 | Teijin Ltd | Culture medium of cell |
-
1988
- 1988-08-29 JP JP63214481A patent/JP2507552B2/en not_active Expired - Fee Related
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS60102187A (en) * | 1983-11-07 | 1985-06-06 | Nippon Zenyaku Kogyo Kk | Continuous cultivation of large amount of cell product |
JPS60156378A (en) * | 1984-01-26 | 1985-08-16 | Teijin Ltd | Culture medium of cell |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2017519497A (en) * | 2014-06-04 | 2017-07-20 | アムジエン・インコーポレーテツド | Method for recovering mammalian cell culture |
JP2020124207A (en) * | 2014-06-04 | 2020-08-20 | アムジエン・インコーポレーテツド | Methods for harvesting mammalian cell cultures |
CN111406105A (en) * | 2018-11-02 | 2020-07-10 | 上海药明生物技术有限公司 | Enhanced perfusion cell culture method with continuous harvest and no cell discharge |
CN115003787A (en) * | 2020-01-15 | 2022-09-02 | 上海药明生物技术有限公司 | Apparatus and method for continuous harvesting of biological material produced by cultured cells |
Also Published As
Publication number | Publication date |
---|---|
JP2507552B2 (en) | 1996-06-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5763275A (en) | Method and apparatus for co-culturing cells | |
US6468792B1 (en) | Process and device for culturing and/or treating cells | |
EP0416061B1 (en) | Cell culture unit with APPARATUS FOR OXYGENATING CULTURE MEDIUM | |
JP2777385B2 (en) | Biological cell culture method, culture system and culture device | |
EP0419234A2 (en) | Cell culture apparatus | |
JPH0728722B2 (en) | Bioreactor equipment | |
JP2019523002A (en) | Fast harvesting with alternating tangential flow | |
JPH0363348B2 (en) | ||
CA2054210A1 (en) | Cell culture system | |
JP2000093159A (en) | Device for incubating and condensing nonadherent cell | |
JPH0265778A (en) | Isolation of cell culture product and change of culture medium | |
AU627449B2 (en) | A culturing apparatus | |
JPS62130683A (en) | Method and apparatus for culturing cell | |
JP2690144B2 (en) | Membrane cell culture device | |
CA2568646A1 (en) | Liquid/gas phase exposure reactor for cell cultivation | |
CA2385362A1 (en) | Method for cultivating cells, a membrane module, utilization of a membrane module and reaction system for cultivation of said cells | |
JP3412364B2 (en) | Cell culture device and cell culture method | |
JPH0257174A (en) | Device for culturing suspended cell | |
KR20240038923A (en) | Method for isolation and purification of extracellular vesicles | |
JPH0659206B2 (en) | Bioreactor | |
JPH0272867A (en) | Method for exchanging cell culture medium | |
JPH06102013B2 (en) | Bioreactor | |
JPH0276571A (en) | Floating cell culture and unit therefor | |
JP2014117190A (en) | Device, module and method for non-adherent cell cultivation | |
JPH0269179A (en) | Method for gas-exchange of cell culture medium |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
LAPS | Cancellation because of no payment of annual fees |